National Health Investors (NHI) Tops Q4 EPS by 6c; issues guidance

National Health Investors (NYSE: NHI) reported Q4 EPS of $0.74, $0.06 better than the analyst estimate of $0.68. Revenue for the quarter came in at $79.47 million versus the consensus estimate of $64.21 million.

GUIDANCE

NHI is issuing its 2024 annual guidance range which includes the following:
NAREIT FFO per diluted common share in a range of $4.31 - $4.37 versus the consensus of $4.33
Normalized FFO per diluted common share in a range of $4.31 - $4.37; and
Normalized FAD in a range of $191.3 million - $194.1 million.

For earnings history and earnings-related data on National Health Investors (NHI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• UBS Downgrades Buzzi Unicem SpA (BZU:IM) (BZZUY) to Sell
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk